• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS INC. THERAKOS CELLEX SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS INC. THERAKOS CELLEX SYSTEM Back to Search Results
Lot Number C129
Device Problem Insufficient Information (3190)
Patient Problem Bronchopneumonia (2437)
Event Date 01/09/2015
Event Type  Injury  
Event Description
The clinical coordinator reported to a monitor that: patient visited a hospital in (b)(6), with cough on (b)(6) 2015.The patient got a chest x-ray test and was diagnosed with bronchial pneumonia and was required hospitalization.The pneumonia was getting better, but the patient remained in the hospital.Post the admission to the hospital, the patient was given the following medications: maxipime for injection 2g/day, codeine phosphate hydrate 3g/day, ambroxol hydrochloride 3 tablets/day.The product was not returned for investigation.
 
Manufacturer Narrative
A bath record review of lot c129 was conducted.There were no nonconformances.The lot met all release requirements.Trends were reviewed for complaint category, cough, and no trends were detected.Based on the assessment, the (b)(6) male with cgvhd developed cough two days after the treatment.Chest xray was performed and bronchial pneumonia was diagnosed.Patient was hospitalized and given antibiotics.Patient's pneumonia is getting better.The health care professional does not think there is relationship between the cough and ecp.This case is serious and unrelated to ecp.This case is reportable due to the medical intervention.The assessment is based on information available at the time of the investigation.No product was returned for analysis; therefore, it could not be determine if this specific product met specification based solely on the information provided by the customer.Complaints are monitored through tracking and trending.If a trend is detected, further action will be taken through the capa/ continuous improvement process.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS CELLEX SYSTEM
Type of Device
CELLEX
Manufacturer (Section D)
THERAKOS INC.
bridgewater NJ
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 baily ave.
buffalo NJ 14211
Manufacturer Contact
440 us route 22 east, suite 140
bridgewater, NJ 08807
MDR Report Key4493701
MDR Text Key5328124
Report Number2523595-2015-00033
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P680003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Nurse
Type of Report Initial
Report Date 01/16/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/01/2016
Device Lot NumberC129
Other Device ID Number10705030100009
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/16/2015
Initial Date FDA Received02/06/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/01/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age58 YR
Patient Weight67
-
-